Progenitor exhausted CD8<sup>+</sup> T (Tpex) cells have recently been identified as a stem-like T cell subset that mediates durable anti-tumor immune responses and represents a pivotal population responsive to immunotherapies. The gene discussed is CD8A; the disease is neoplasm.